Clinical trial
Imaging for Early Response Prediction to EGF-receptor Blocking Monoclonal Antibodies in Combination Therapy for Colorectal Cancer
NCT00828620 is registered in ClinicalTrials.gov with Universitaire Ziekenhuizen KU Leuven as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Imaging for Early Response Prediction to EGF-receptor Blocking Monoclonal Antibodies in Combination Therapy for Colorectal Cancer
- Lead sponsor
- Universitaire Ziekenhuizen KU Leuven
- Phase
- Observational
- Overall status
- Terminated
- Start date
- January 31, 2009
- Completion date
- June 30, 2012
- Enrollment
- 21 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
metastatic colorectal cancer